Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Peter Chin, M.D.

Group Medical Director, Neuroscience, SPECTRUM Medical Unit, US Medical Affairs at Genentech Inc


Peter S. Chin, MD, MSHS, is Group Medical Director for Neuroscience in US Medical Affairs at Genentech. A neurologist, outcomes researcher and clinical trialist, he has held clinical development and medical affairs roles at Genentech, Roche and Novartis working in MS and other neuroscience disease areas. Dr. Chin has been active on numerous committees and working groups in MS including the NIH-NINDS Common Data Elements, EMA guidance workshop, and various academic-industry consortia, and has served as ad-hoc peer reviewer for multiple neurological journals and for scientific meetings of the American Academy of Neurology. He completed his undergraduate degree in molecular and cell biology from UC Berkeley, M.D. at Dartmouth Medical School, neurology residency at the University of Washington, and fellowship as a Robert Wood Johnson Foundation Clinical Scholar at UCLA, where he also obtained an M.S. in health services research through the School of Public Health.

Agenda Sessions